Aethlon Medical, Inc. (AEMD) vs bioAffinity Technologies, Inc. (BIAF)

A side-by-side comparison of Aethlon Medical, Inc. and bioAffinity Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Aethlon Medical, Inc. logo
AEMD
Aethlon Medical, Inc.
$3M
$6.30HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
bioAffinity Technologies, Inc. logo
BIAF
bioAffinity Technologies, Inc.
$3M
$6.30HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT

Total return — AEMD vs BIAF

growth of $100 · dividends reinvested · last 4y
AEMD -99.9% (-80.8%/yr)BIAF -99.8% (-79.8%/yr)BIAF compounded faster over this window
020406080100Start $1002023202420252026$0$0
AEMD BIAF

AEMD vs BIAF: by the numbers

  • •AEMD is the larger company ($3M vs $3M market cap).
  • •Both run net losses; AEMD's is the smaller (0.00% vs -257.33% net margin).

Metrics side by side

Valuation

MetricAEMDBIAF
P/S ratioN/A0.45
P/B ratio0.640.70

Profitability

MetricAEMDBIAF
Gross margin0.00%23.21%
Operating margin0.00%-171.58%
Net margin0.00%-257.33%
ROE-133.43%-402.92%
ROIC-133.29%-237.93%

Growth (annualized)

MetricAEMDBIAF
Total return CAGR (5Y)-78.27%N/A

Go deeper

Full AEMD analysisFull BIAF analysisInteractive comparison tool

Dig into the metrics

Aethlon Medical ROEbioAffinity Technologies ROEAethlon Medical operating marginbioAffinity Technologies operating marginAethlon Medical revenue growthbioAffinity Technologies revenue growthAethlon Medical free cash flowbioAffinity Technologies free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.